Increased Plasma Rifabutin Levels with Concomitant Fluconazole Therapy in HIV-Infected Patients

Abstract

Fluconazole significantly increases the systemic exposure of both rifabutin and LM565. This pharmacokinetic interaction offers a mechanism that may explain the changes reported in both the efficacy and toxicity of rifabutin with concomitant fluconazole therapy.